Nasdaq:BODI
Beachbody Company, Inc.
A struggling direct-to-consumer health company facing significant revenue contraction and persistent net losses despite a massive marketing expenditure strategy.
Key Metrics
Investment Thesis
Bull Case
The narrowing net loss trajectory and massive cash on hand of $20.2M provide a runway for management to execute a strategic pivot or acquisition without immediate insolvency risk, potentially unlocking hidden value if the company successfully revitalizes its product lines.
Bear Case
Investors should avoid this stock due to the alarming 40% revenue contraction over three years, a current net loss of $71.6M that dwarfs operating cash flow of only $2.6M, and a massive marketing expense of $200.1M that fails to generate positive earnings before interest and taxes.
About Beachbody Company, Inc.
Beachbody Company Inc. operates primarily in the health and wellness industry, offering a comprehensive ecosystem of fitness programs, nutritional supplements, and coaching services to individuals globally through its direct sales model.
Analysis
Management Discussion
The company reported a net loss of $71.6M in 2024, representing an improvement from the prior year's $-152.6M loss, yet this follows a catastrophic revenue drop from $692.2M in 2022 to $418.8M today, suggesting that current profitability is not sustainable without a complete business model overhaul.
Industry Overview
The global health and wellness market is highly competitive with shifting consumer preferences toward digital-first fitness solutions and sustainable nutrition, challenging traditional direct sales models reliant on physical product distribution.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $692.2M | $527.1M | $418.8M |
| Cost of Revenue | $322.6M | $204.0M | $131.5M |
| Gross Profit | $369.6M | $323.1M | $287.3M |
| Operating Expenses | $572.7M | $464.1M | $353.6M |
| Operating Income | $-203.2M | $-141.0M | $-66.2M |
| R&D | $4.4M | $2.7M | $1.6M |
| G&A | $78.4M | $57.9M | $49.2M |
| Marketing | $360.0M | $282.1M | $200.1M |
| Stock-Based Comp | $17.6M | $23.9M | $17.1M |
| D&A | $74.8M | $39.6M | $31.4M |
| Depreciation | $56.6M | $34.5M | $31.4M |
| Amortization | $18.3M | $5.1M | — |
| Other OpEx | $129.9M | $121.3M | $102.6M |
| Non-Operating Income | $5.9M | $-11.6M | $-5.2M |
| Interest Expense | $3.4M | $8.9M | $6.9M |
| Interest Income | — | — | $1.2M |
| Pre-Tax Income | $-197.2M | $-152.6M | $-71.4M |
| Income Tax | $-3.1M | $37.0K | $239.0K |
| Continuing Ops | $-194.2M | $-152.6M | $-71.6M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-194.2M | $-152.6M | $-71.6M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-194.2M | $-152.6M | $-71.6M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $186.5M | $119.3M | $78.7M |
| Cash & Equivalents | $80.1M | $33.4M | $20.2M |
| Accounts Receivable | $866.0K | $1.3M | $1.4M |
| Inventory | $54.1M | $25.0M | $16.3M |
| Other Current Assets | $51.4M | $59.6M | $40.7M |
| Long-Term Assets | $256.9M | $157.6M | $95.9M |
| PP&E (Net) | $74.1M | $45.1M | $12.7M |
| Intangibles | $8.2M | — | — |
| Goodwill | — | $85.2M | $65.2M |
| Operating Leases | $5.0M | $3.1M | $3.1M |
| Other LT Assets | $169.6M | $24.2M | $14.9M |
| Total Assets | $443.4M | $276.8M | $174.6M |
| Current Liabilities | $184.6M | $165.2M | $127.6M |
| Accounts Payable | $17.9M | $10.7M | $9.5M |
| Current Debt | $1.2M | $8.1M | $9.5M |
| Other Current Liab | $101.0M | $104.3M | $83.6M |
| Long-Term Liabilities | $47.2M | $28.9M | $18.7M |
| Long-Term Debt | $39.7M | $21.5M | $9.7M |
| Other LT Liab | $7.5M | $7.4M | $9.1M |
| Total Liabilities | $231.9M | $194.1M | $146.4M |
| Shareholders' Equity | $211.5M | $82.8M | $28.2M |
| Paid-In Capital | $630.7M | $654.7M | $671.7M |
| Retained Earnings | $-419.2M | $-571.9M | $-643.5M |
| AOCI | $37.0K | $-23.0K | $-49.0K |
| Total L&E | $443.4M | $276.8M | $174.6M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-194.2M | $-152.6M | $-71.6M |
| Non-Cash Adjustments | $245.1M | $171.2M | $132.3M |
| Working Capital Changes | $-98.1M | $-41.1M | $-58.1M |
| Cash from Operations | $-47.2M | $-22.5M | $2.6M |
| Capital Expenditures | $26.5M | $6.6M | $4.5M |
| Cash from Investing | $-26.5M | $-10.8M | $1.1M |
| Cash from Financing | $47.6M | $-13.7M | $-15.9M |
| FX Effect | $-858.0K | $398.0K | $-974.0K |
| Net Change in Cash | $-27.0M | $-46.7M | $-13.2M |
| Beginning Cash | $107.1M | $80.1M | $33.4M |
| Ending Cash | $80.1M | $33.4M | $20.2M |
Frequently Asked Questions
How does Beachbody Company, Inc. make money?
The company derives revenue from the sale of core workout programs such as P90X and 21 Day Fix, nutritional products including protein shakes and meal replacements, and coaching services facilitated through its independent consultant network.
What are the main risks for BODI?
Severe and accelerating revenue decline over the last three years indicating potential obsolescence of core products or loss of consumer interest, persistent operating losses exceeding $70 million in 2024, heavy reliance on high marketing spend ($200M) to cover costs without generating profit, and a significant accumulated deficit suggesting long-term solvency concerns.
What is BODI's competitive advantage?
Strong brand recognition in the home fitness niche, a deeply entrenched direct sales force that provides personalized customer retention, and a proprietary digital platform integrating workout tracking with supplement purchases.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.